Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-20

Clinical Trial Update: Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of cyclosporine ophthalmic emulsion in post-LASIK patients has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporine ophthalmic emulsion (Restasis) (cyclosporine ophthalmic emulsion)

Snippet

Sponsor: Allergan | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2011-12-20